Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Chemours (CC) Other Accumulated Expenses (2016 - 2025)

Historic Other Accumulated Expenses for Chemours (CC) over the last 11 years, with Q3 2025 value amounting to $165.0 million.

  • Chemours' Other Accumulated Expenses rose 2313.43% to $165.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $165.0 million, marking a year-over-year increase of 2313.43%. This contributed to the annual value of $115.0 million for FY2024, which is 2229.73% down from last year.
  • Chemours' Other Accumulated Expenses amounted to $165.0 million in Q3 2025, which was up 2313.43% from $222.0 million recorded in Q2 2025.
  • Over the past 5 years, Chemours' Other Accumulated Expenses peaked at $239.0 million during Q2 2022, and registered a low of $65.0 million during Q1 2021.
  • Over the past 5 years, Chemours' median Other Accumulated Expenses value was $154.0 million (recorded in 2021), while the average stood at $157.7 million.
  • Per our database at Business Quant, Chemours' Other Accumulated Expenses surged by 18000.0% in 2022 and then plummeted by 3807.53% in 2023.
  • Over the past 5 years, Chemours' Other Accumulated Expenses (Quarter) stood at $173.0 million in 2021, then grew by 12.14% to $194.0 million in 2022, then decreased by 23.71% to $148.0 million in 2023, then fell by 22.3% to $115.0 million in 2024, then skyrocketed by 43.48% to $165.0 million in 2025.
  • Its Other Accumulated Expenses was $165.0 million in Q3 2025, compared to $222.0 million in Q2 2025 and $117.0 million in Q1 2025.